Literature DB >> 5279046

Revised primary structure for human growth hormone.

H D Niall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5279046     DOI： 10.1038/newbio230090a0

Source DB:  PubMed          Journal:  Nat New Biol        ISSN： 0090-0028


× No keyword cloud information.
  10 in total

Review 1.  Human growth hormone doping in sport.

Authors:  M Saugy; N Robinson; C Saudan; N Baume; L Avois; P Mangin
Journal:  Br J Sports Med       Date:  2006-07       Impact factor: 13.800

2.  The pituitary gland: a brief history.

Authors:  Solomon Alexander Kaplan
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 3.  A generalized homology correlation for various hormones and proteins.

Authors:  B Weinstein
Journal:  Experientia       Date:  1972-12-15

Review 4.  Studies on growth hormones.

Authors:  A C Paladini; J M Dellacha; J A Santome
Journal:  Mol Cell Biochem       Date:  1973-12-15       Impact factor: 3.396

5.  Partial sequence of the tyrosine region of neocarzinostatin.

Authors:  C B Glaser; H Maeda; J Meienhofer; H D Niall
Journal:  Experientia       Date:  1972-07-15

6.  Sequence comparison of human pituitary growth hormone, human chorionic somatomammotropin and ovine pituitary lactogenic hormone.

Authors:  T A Brewley; C H Li
Journal:  Experientia       Date:  1971

7.  Structural relationships among growth hormones and prolactins.

Authors:  M Wallis
Journal:  Biochem J       Date:  1971-12       Impact factor: 3.857

8.  Human growth hormone.

Authors:  J A Parsons
Journal:  Br Med J       Date:  1971-05-22

Review 9.  New directions in the chemistry of natural products: the organic chemist as a pathfinder for biochemistry and medicine.

Authors:  B Witkop
Journal:  Experientia       Date:  1971-10-15

Review 10.  Advances in differential diagnosis and management of growth hormone deficiency in children.

Authors:  Camille Hage; Hoong-Wei Gan; Anastasia Ibba; Giuseppa Patti; Mehul Dattani; Sandro Loche; Mohamad Maghnie; Roberto Salvatori
Journal:  Nat Rev Endocrinol       Date:  2021-08-20       Impact factor: 43.330
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.